Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewsIndia

Remdesivir price should be slashed to Rs 1200, says Maharashtra Health Minister Rajesh Tope

Maharashtra is one among nine other states that have shown a steep rise in the daily COVID-19 cases accounting for 83.02 percent of the new infections, the Union Health Ministry said on Monday.

April 12, 2021 / 10:11 PM IST
remdesivir

remdesivir


Rajesh Tope, the state health minister of Maharashtra has said that companies that produce Remdesivir should double their production.

The minister also added that the price of this anti-viral drug, used in the treatment of COVID-19, be reduced to Rs 1,200-Rs 1,300, ANI reported.

Maharashtra is one among nine other states that have shown a steep rise in the daily COVID-19 cases accounting for 83.02 percent of the new infections, the Union Health Ministry said on Monday.

However, as of now Maharashtra has ruled out the possibility of a lockdown. Tope said that a decision regarding the imposition of a lockdown in Maharashtra will be taken after the state Cabinet meeting on April 14.

The state has been facing a shortage of Remdesivir amid a surge in cases. To tackle the shortage, the state government has decided to set up district-level control rooms to ensure a smooth supply of these injections and prevent hoarding and black-marketing of the drug.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Maharashtra reported 51,751 new COVID-19 cases, 52,312 recoveries & 258 deaths in the last 24 hours.
Moneycontrol News
first published: Apr 12, 2021 10:06 pm

stay updated

Get Daily News on your Browser
Sections